News and Analysis

Andreessen Horowitz leads Series A round for Octant

Octant Inc, a synthetic biology drug discovery company, has raised $30 million in Series A financing.

-

Octant Inc, a synthetic biology drug discovery company, has raised $30 million in Series A financing. The lead backer was Andreessen Horowitz.

Source: Press Release